Study Guide for Pharmacology - Elsevier E-Book on VitalSource, 12th Edition

by Mary B. Winton, PhD, MSN, RN, Linda E. McCuistion, PhD, MSN, RN, Kathleen Vuljoin DiMaggio, MSN, RN and Jennifer J. Yeager, PhD, MSN, RN

Elsevier eBook on VitalSource

ISBN: 9780443116346

Publication Date: 04-28-2025

Page Count: 320

Imprint: Elsevier

List Price: $37.99

Was $37.99

Now $33.43

Or $0.00 with a valid access code

Reinforce your understanding of nursing pharmacology and patient-centered care for NGN success and medication safety! Corresponding to the chapters in McCuistion’s Pharmacology: A Patient-Centered Nursing Process Approach, 12^th Edition, this practical study guide provides hundreds of exercises, questions, drug calculation problems, and case studies to help you review and apply pharmacology and drug calculation concepts and content. The new edition features Next-Generation NCLEX^® Examination (NGN)–style case studies to prepare your for the latest NCLEX® Exam. With this practical study guide, you will apply your knowledge of pharmacology to clinical practice, enhance your decision-making abilities, and develop your clinical judgment skills for NGN success and safe medication practice.

Related Products
- 12th Edition
  Pharmacology
  Paperback
  
  ISBN: 9780443115257
- 12th Edition
  Pharmacology - Elsevier eBook on VitalSource
  Elsevier eBook on VitalSource
  
  ISBN: 9780443116407
Key Features
- UPDATED! Content matches the updates in the 12^th edition of the McCuistion textbook
- Each chapter features helpful learning aids, including a Study Questions section (fill-in-the-blank, matching, true-false), an NCLEX^® Review Questions section, and a Case Studies section, which includes traditional case studies as well as Next-Generation NCLEX^® Exam (NGN)–style case studies
- Authentic and current sample drug labels throughout mirror true-to-life practice in working with drug information
- Focus on safety includes a special icon that calls attention to questions related to the AACN Essentials priority of safe patient care
- Answers for all exercises are provided at the back of the book to facilitate self-study, with detailed rationales included for all application-level questions and case study questions
- A drug calculation review chapter follows the outline of the corresponding textbook chapter, offering you the opportunity to test your knowledge and skill in drug dosage calculation
Contents

UNIT I: INTRODUCTION TO PHARMACOLOGY
1. Clinical Judgment Management Model and the Nursing Process
2. Drug Development and Ethical Considerations
3. Pharmacokinetics and Pharmacodynamics
4. Pharmacogenetics
5. Complementary and Alternative Therapies
6. Pediatric Considerations
7. Geriatric Considerations
8. Drugs in Substance Use Disorder

UNIT II: PHARMACOTHERAPY AND DRUG ADMINISTRATION
9. Safety and Quality
10. Drug Administration
11. Drug Labels and Dosage Calculations

UNIT III: MAINTENANCE OF HOMEOSTASIS
12. Fluid Volume and Electrolytes
13. Vitamin and Mineral Replacement
14. Nutritional Support

UNIT IV: AUTONOMIC NERVOUS SYSTEM DRUGS
15. Adrenergic Agonists and Antagonists
16. Cholinergic Agonists and Antagonists

UNIT V: CENTRAL AND PERIPHERAL NERVOUS SYSTEM DRUGS
17. Stimulants
18. Depressants
19. Antiseizure Drugs
20. Drugs for Parkinsonism and Alzheimer Disease
21. Drugs for Neuromuscular Disorders and Muscle Spasms

UNIT VI: MENTAL AND BEHAVIORAL HEALTH DRUGS
22. Antipsychotics and Anxiolytics
23. Antidepressants and Mood Stabilizers

UNIT VII: PAIN AND INFLAMMATION MANAGEMENT DRUGS
24. Antiinflammatories
25. Analgesics

UNIT VIII: ANTIMICROBIAL DRUGS
26. Penicillins, Other Beta-lactams, and Cephalosporins
27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, and Lipopeptides
28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones
29. Sulfonamides and Nitroimidazoles Antibiotics
30. Antituberculars, Antifungals, and Antivirals
31. Antimalarials, Anthelmintics, and Peptides

UNIT IX: IMMUNOLOGIC DRUGS
32. HIV- and AIDS-Related Drugs
33. Transplant Drugs
34. Vaccines

UNIT X: ANTINEOPLASTICS AND BIOLOGIC RESPONSE MODIFIERS
35. Anticancer Drugs
36. Targeted Therapies to Treat Cancer
37. Biologic Response Modifiers

UNIT XI: RESPIRATORY DRUGS
38. Upper Respiratory Disorders
39. Lower Respiratory Disorders

UNIT XII: CARDIOVASCULAR DRUGS
40. Cardiac Glycosides, Antianginals, and Antidysrhythmics
41. Diuretics
42. Antihypertensives
43. Anticoagulants, Antiplatelets, and Thrombolytics
44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow

UNIT XIII: GASTROINTESTINAL DRUGS
45. Gastrointestinal Tract Disorders
46. Antiulcer Drugs

UNIT XIV: EYE, EAR, AND SKIN DRUGS
47. Eye and Ear Disorders
48. Dermatologic Disorders

UNIT XV: ENDOCRINE DRUGS
49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
50. Antidiabetics

UNIT XVI: RENAL AND UROLOGIC DRUGS
51. Urinary Disorders

UNIT XVII: REPRODUCTIVE AND GENDER-RELATED DRUGS
52. Pregnancy and Preterm Labor
53. Labor, Delivery, and Postpartum
54. Neonatal and Newborn
55. Women’s Reproductive Health
56. Men’s Reproductive Health
57. Sexually Transmitted Infections

UNIT XVIII: EMERGENCY DRUGS
58. Adult and Pediatric Emergency Drugs

Answer Key
Authors

Mary B. Winton, PhD, MSN, RN, Associate Professor, Tarleton State University, Stephenville, Texas, USA, Linda E. McCuistion, PhD, MSN, RN, Professor (Ret.), University of Holy Cross, New Orleans, Louisiana, USA, Kathleen Vuljoin DiMaggio, MSN, RN, Professor Emerita, University of Holy Cross, New Orleans, Louisiana, USA and Jennifer J. Yeager, PhD, MSN, RN, Associate Professor, Tarleton State University, Stephenville, Texas, USA
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - No information about nonvisual reading is available
- Conformance
  - For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
  - For queries regarding accessibility information, contact [email protected]
  - The publication was certified on 18-11-2025
- Navigation
  - Table of contents to all chapters of the text via links
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.